Mesothelioma

• Science & Technology
• Health & Medicine

10 ways we’ve influenced progress in lung cancer

From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 10 ways we have worked towards progress in lung cancer. From uncovering some of the causes of lung cancer, through to contributing to drugs used to treat it, here are 10 ways we have worked towards progress in lung cancer.

1 November 2023

• Health & Medicine

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab. People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab.

30 January 2021

• Science & Technology
• Health & Medicine

Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease. A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

26 September 2017

• Health & Medicine

Cancer Research UK and Biotecnol to trial new immuno-oncology treatment for advanced tumours

Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours. Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.

10 August 2017

• Science & Technology
• Health & Medicine

The trans-Atlantic quest to find a winning combination of cancer drugs

An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time. An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.

30 September 2016

• Health & Medicine

Study sheds new light on asbestos-related cancer

US scientists analysing tumour samples from patients with mesothelioma have mapped out the gene faults associated with the disease in unprecedented detail. US scientists analysing tumour samples from patients with mesothelioma have mapped out the gene faults associated with the disease in unprecedented detail.

1 March 2016

• Health & Medicine

DIYers urged to be asbestos aware

A new survey has highlighted the need for Britons to improve their awareness of asbestos. A new survey has highlighted the need for Britons to improve their awareness of asbestos.

5 July 2010

• Health & Medicine

'Baby boom' carpenters at greatest risk of developing asbestos related cancer

One in 17 British carpenters born in the 1940s will die of mesothelioma - a cancer of the lining of the lung caused by asbestos - according to new research* published in the British Journal of Cancer. One in 17 British carpenters born in the 1940s will die of mesothelioma - a cancer of the lining of the lung caused by asbestos - according to new research* published in the British Journal of Cancer.

3 March 2009

Nano no-no? You cannot be serious...

22 May 2008

Mesothelioma deaths to peak by 2015

Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this weekїs British Journal of Cancer1. Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this weekїs British Journal of Cancer1.

15 February 2005

• Health & Medicine

New drug boost for lung cancer sufferers

Clinical trials of a new anticancer drug combination carried out by Cancer Research UK scientists at Newcastle University show that it has the potential to almost double the life expectancy of sufferers of mesothelioma - a form of lung cancer which affects around 1,700 people in the UK every year - according to a report published in the Journal of Clinical Oncology1. Clinical trials of a new anticancer drug combination carried out by Cancer Research UK scientists at Newcastle University show that it has the potential to almost double the life expectancy of sufferers of mesothelioma - a form of lung cancer which affects around 1,700 people in the UK every year - according to a report published in the Journal of Clinical Oncology1.

2 August 2002